Skip to main content
. 2007 Dec 26;105(2):663–667. doi: 10.1073/pnas.0705286104

Fig. 5.

Fig. 5.

Effects of KB2115 on biomarkers for cholesterol synthesis and degradation after once-daily dosing for 2 weeks displayed as percent change from baseline for ratios between C4 and cholesterol (A; P = 0.01, 200-μg group differs from placebo) and ratios between lathosterol and cholesterol (B).